Myocardial ischemia caused by distal coronary-artery constriction in stable angina pectoris

The New England Journal of Medicine
G PupitaF Crea

Abstract

In patients with stable coronary artery disease, the ischemic threshold for the production of effort-related angina is often quite variable. Although this feature is commonly attributed to changes in the caliber of coronary arteries at the site of stenosis, it could also be caused by the constriction of distal vessels, collateral vessels, or both. In order to test this hypothesis, we studied 11 patients with stable angina, total occlusion of a single coronary artery that was supplied by collateral vessels, normal ventricular function, no evidence of coronary-artery spasm, and no other coronary stenoses. These conditions precluded the modulation of coronary flow by vasomotion at the site of the coronary stenosis. The ischemic threshold--assessed by multiplying the heart rate by the systolic blood pressure at a 1-mm depression of the ST segment during exercise testing--increased by 19 percent after the administration of nitroglycerin (P less than 0.05) and decreased by 18 percent after the administration of ergonovine (P less than 0.01). Ambulatory electrocardiographic monitoring of the patients when not receiving treatment detected 73 ischemic episodes that, in keeping with the history, showed variations of 25 to 52 beats per mi...Continue Reading

References

Mar 1, 1977·The American Journal of Cardiology·S J Schang, C J Pepine
Oct 15, 1989·The American Journal of Cardiology·S W LarkinA Maseri
Jun 1, 1989·Circulation·K G PetersD G Harrison
Jun 1, 1989·American Heart Journal·T YamakadoH Takezawa
Jun 1, 1988·The American Journal of Physiology·G A VallegaR W Alexander
Jul 1, 1988·American Journal of Hypertension·N Hollenberg
Aug 1, 1986·Journal of the American College of Cardiology·S E Epstein, R O Cannon
Nov 1, 1973·The Journal of Clinical Investigation·M V CohenE S Kirk
Jun 1, 1972·The American Journal of Cardiology·J SchaperW Schaper
Jan 1, 1984·Japanese Heart Journal·H AkitaH Fukuzaki
Mar 1, 1983·Journal of the American College of Cardiology·A C CecchiP F Fazzini

❮ Previous
Next ❯

Citations

Feb 1, 1993·Catheterization and Cardiovascular Diagnosis·K YamanishiA Igawa
Mar 1, 1993·Journal of the American College of Cardiology·N G UrenA Maseri
Apr 1, 1993·Journal of the American College of Cardiology·H el-TamimiA Maseri
Aug 1, 1994·Journal of the American College of Cardiology·T J AndersonA C Yeung
Sep 1, 1995·Journal of the American College of Cardiology·G SambucetiA L'Abbate
Jun 1, 1996·Journal of the American College of Cardiology·A ChauhanP M Schofield
May 30, 1996·The American Journal of Cardiology·J Abrams
Jun 26, 1997·The American Journal of Cardiology·H C Lewin, D S Berman
Feb 1, 1991·Journal of the American College of Cardiology·A MaseriT Crake
Mar 1, 1991·Journal of the American College of Cardiology·J C KaskiA Maseri
Jul 1, 1997·Journal of the American College of Cardiology·D Tzivoni, S Maybaum
Feb 17, 2000·Journal of the American College of Cardiology·M MarzilliA L'Abbate
Jan 1, 1995·Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology·G Sambuceti, O Parodi
Jan 31, 1991·The New England Journal of Medicine·M O'Rourke
Nov 28, 1991·The New England Journal of Medicine·A Maseri
Feb 23, 2007·The New England Journal of Medicine·Paolo G Camici, Filippo Crea
Apr 16, 2004·Heart·David C Crossman
Jun 1, 1993·British Heart Journal·A ChauhanP M Schofield
Oct 1, 1996·Heart·N G Uren, T Crake
Feb 8, 2011·American Journal of Physiology. Heart and Circulatory Physiology·Juan Carlos RoblesCristine L Heaps
Feb 24, 2004·Journal of Applied Physiology·Cristine L HeapsDouglas K Bowles
Feb 10, 2009·Circulation Journal : Official Journal of the Japanese Circulation Society·Attilio MaseriHiroaki Shimokawa
Jan 1, 2010·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Udo SechtemAli Yilmaz
Jan 1, 2010·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Mario MarzilliDoralisa Morrone
Jul 14, 2010·Current Problems in Cardiology·Robert A O'Rourke
Jan 3, 2009·Heart, Lung & Circulation·John F BeltramePaolo Camici
Dec 17, 2014·International Heart Journal·Toru MiyazakiMitsuaki Isobe
Aug 1, 1992·Current Problems in Cardiology·J Abrams
Jul 1, 1993·International Journal of Cardiology·R SteffensenS Haunsø
Dec 1, 1991·American Heart Journal·T T Bashour
Apr 20, 2016·Cardiovascular Drugs and Therapy·Gaetano Antonio Lanza, Filippo Crea
Feb 22, 2012·Journal of the American College of Cardiology·Alfredo R GalassiCorrado Tamburino

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.